Abstract 275: Effect of Customized Cardiovascular Education on Patient Beliefs and Behaviors Around Cardiovascular Medications

Linda Gordon,Nicole Ansani

DOI: https://doi.org/10.1161/circoutcomes.5.suppl_1.a275

2012-04-01

Abstract:Objective: The objective of this project was to describe the effect of tailored cardiovascular (CV) patient education on beliefs and knowledge about medication in a nurse managed CV risk reduction clinic. Methods: This prospective project was conducted on patients 18 years of age or older referred to usual care at a risk reduction clinic. The primary analysis was change in scores on the Beliefs about Medications Questionnaire (BMQ) pre and post customized CV education. Education included a background/risk assessment, personalized general information, disease management education, and therapeutic lifestyle intervention. The BMQ evaluates 2 domains: necessity and concerns about medications; and general overuse and harm of medications. Secondary analysis included pre/post scores on a patient knowledge assessment (2 questions: I have received education on the importance of continuing (1) cholesterol medications and (2) antiplatelet medications) and the relationship between specific demographics and BMQ scores pre/post. A power calculation determined 45 patients were needed. Data were analyzed using paired t-tests. Results Forty-five patients were enrolled and 40 completed the project. Average age was 64 years, 55% were male, and average number of medications was 4.5. Results of the BMQ demonstrated significant improvements in response to the following (scale 1 [strongly disagree] - 5 [strongly agree]): “my medications are a mystery to me” (average score pre=2.7 vs. post=2.2, p<0.05) and medications do more harm than good (average score pre = 2.1 vs. post = 2.0; p<0.05). Scores on all other questions were not significantly different pre/post. A higher number of patients responded “yes” that they were instructed on the importance of continuing cholesterol medications and antiplatelet medications pre/post (p<0.05 for both). Age, gender, and education level did not correlate with BMQ scores pre/post. Patients receiving primary prevention therapies showed significant improvements in score in 4 components of the specific necessity and concerns (p<0.05 for all). In 2 areas of general overuse and harm, there were both increases and decreases in scores, respectively (p<0.05 for all). Patients receiving secondary prevention therapies showed significant changes in scores in 12 components. With regard to specific necessity and concern, scores improved in 4 components (p<0.05 for all). A decrease in perception was seen in 1 component (p<0.05). General overuse and harm scores showed improvements in 5 components (p<0.05 for all). A decrease in perception was seen in 2 components (p<0.05 for all). Conclusions: Customized CV education results in improvements in patients’ beliefs and knowledge about medications. These data have provided a basis to further evaluate education methods in this CV practice. Future implications are to investigate changes in BMQ scores with clinical markers such as LDL and blood pressure goal attainment.